|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.36 USD | -3.65% |
|
-1.56% | -66.69% |
| Dec. 03 | American Bitcoin steadies after share lock-up expiry sparks near 40% plunge | RE |
| Dec. 03 | American Bitcoin steadies after share lock-up expiry sparks near 40% plunge | RE |
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
Revenues | 2.32M | 1.47M | 4.13M | 3.62M |
Total Revenues | 2.32M | 1.47M | 4.13M | 3.62M |
Cost of Goods Sold, Total | - | 54.5K | 165K | 619K |
Gross Profit | 2.32M | 1.42M | 3.97M | 3M |
Selling General & Admin Expenses, Total | 4.15M | 10.97M | 10.16M | 134M |
R&D Expenses | 2.81M | 13.63M | 9.72M | 49.1M |
Depreciation & Amortization - (IS) | - | 58.7K | 59.6K | 2.93M |
Other Operating Expenses, Total | 6.96M | 24.66M | 19.93M | 186M |
Operating Income | -4.64M | -23.25M | -15.97M | -183M |
Interest Expense, Total | -714K | -2.04M | -39.43M | -3.09M |
Interest And Investment Income | - | - | - | 14.72M |
Net Interest Expenses | -714K | -2.04M | -39.43M | 11.63M |
Other Non Operating Income (Expenses) | -59.11M | 75.81M | -2.79M | -226M |
EBT, Excl. Unusual Items | -64.47M | 50.52M | -58.19M | -398M |
Merger & Related Restructuring Charges | - | - | - | -2.58M |
Other Unusual Items | - | - | - | -542K |
EBT, Incl. Unusual Items | -64.47M | 50.52M | -58.19M | -401M |
Income Tax Expense | - | 200 | 1.1K | - |
Earnings From Continuing Operations | -64.47M | 50.52M | -58.19M | -401M |
Net Income to Company | -64.47M | 50.52M | -58.19M | -401M |
Net Income - (IS) | -64.47M | 50.52M | -58.19M | -401M |
Net Income to Common Incl Extra Items | -64.47M | 50.52M | -58.19M | -401M |
Net Income to Common Excl. Extra Items | -64.47M | 50.52M | -58.19M | -401M |
Per Share Items | ||||
Net EPS - Basic | -0.64 | 0.51 | -0.58 | -2.36 |
Basic EPS - Continuing Operations | -0.64 | 0.51 | -0.58 | -2.36 |
Basic Weighted Average Shares Outstanding | 100M | 100M | 100M | 170M |
Net EPS - Diluted | -0.64 | 0.51 | -0.58 | -2.36 |
Diluted EPS - Continuing Operations | -0.64 | 0.51 | -0.58 | -2.36 |
Diluted Weighted Average Shares Outstanding | 100M | 100M | 100M | 170M |
Normalized Basic EPS | -0.4 | 0.32 | -0.36 | -1.47 |
Normalized Diluted EPS | -0.4 | 0.32 | -0.36 | -1.47 |
Supplemental Items | ||||
EBITDA | -4.64M | -23.19M | -15.91M | -181M |
EBITA | -4.64M | -23.25M | -15.97M | -181M |
EBIT | -4.64M | -23.25M | -15.97M | -183M |
EBITDAR | - | - | - | -180M |
Effective Tax Rate - (Ratio) | - | 0 | -0 | - |
Normalized Net Income | -40.29M | 31.58M | -36.37M | -249M |
Interest on Long-Term Debt | 654K | - | 39.43M | 3.09M |
Supplemental Operating Expense Items | ||||
Selling and Marketing Expenses | 416K | 626K | 1.28M | 6.38M |
General and Administrative Expenses | 3.74M | 10.35M | 8.88M | 128M |
Research And Development Expense From Footnotes | 2.81M | 13.63M | 9.72M | 49.1M |
Net Rental Expense, Total | - | - | - | 742K |
Imputed Operating Lease Interest Expense | - | - | - | 622K |
Imputed Operating Lease Depreciation | - | - | - | 120K |
Stock-Based Comp., R&D Exp. (Total) | - | - | - | 30.14M |
Stock-Based Comp., G&A Exp. (Total) | - | - | - | 77.24M |
Total Stock-Based Compensation | - | - | - | 107M |
Select your edition
All financial news and data tailored to specific country editions
